Animal models of Parkinson's disease: An updated overview, a rat model of Parkinson's disease, vol.15, pp.750-761, 2015. ,
,
IMABio team Clinical. 2016. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging, Polyamines: Bio-Molecules with, vol.139, pp.1252-1264, 2018. ,
, Diverse Functions in Plant and Human Health and Disease, Front Chem, vol.6, p.10
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice, Behav Brain Res, vol.162, pp.187-192, 2005. ,
Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain, J Neurol Neurosurg. Psychiatry, vol.79, pp.407-419, 2008. ,
Non-motor symptoms in Parkinson's disease, Parkinsonism Relat Disord, vol.94, pp.318-328, 2016. ,
, , vol.3, p.17013, 2017.
A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999, J Nucl Med, vol.58, p.413, 2017. ,
Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy, J Neurochem, vol.81, pp.954-960, 2002. ,
,
Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation, J Neuroinflammation, vol.13, p.137, 2016. ,
,
, Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases, Free Radic Biol Med, vol.45, pp.686-699
,
Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders, Nat Rev Drug Discov, vol.9, pp.971-988, 2010. ,
Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain, J Cereb Blood Flow Metab, vol.11, pp.1493-1499, 2011. ,
,
In vivo PET quantification of the dopamine transporter in rat brain with, Nucl Med Biol, vol.41, issue.1, pp.106-113, 2014. ,
Assessment of the Protection of, 2015. ,
, Dopaminergic Neurons by an alpha7 Nicotinic Receptor Agonist
-999 in a Parkinson's Disease Rat Model, Front Med (Lausanne), vol.2, p.61 ,
, , 2013.
PET imaging of a unilateral Parkinsonian animal model, Am J Nucl Med Mol Imaging, vol.3, pp.129-141 ,
,
Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine, Front Aging Neurosci, vol.105, p.65, 2008. ,
Emerging therapies for, 2014. ,
, Parkinson's disease: from bench to bedside, Pharmacol Ther, vol.144, pp.123-133
Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update, J Nucl Med, vol.54, pp.1331-1338, 2013. ,
,
Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging, Mol Imaging, 2016. ,
Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease, PLoS One, vol.7, 2012. ,
Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study, 2012. ,
, Ungerstedt, U. 1968. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons, Eur J Pharmacol, vol.73, p.45
Are rodent models of Parkinson's disease behaving as they should?, Behav Brain Res, 2017. ,
,
, Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra, J Neurochem, vol.75, pp.540-552
Neuroinflammation in Parkinson's disease and its potential as therapeutic target, Transl Neurodegener, vol.4, p.19, 2015. ,
Inborn Errors of Long-Chain Fatty Acid beta-Oxidation Link Neural Stem Cell Self-Renewal to, Curr Metabolomics, vol.1, pp.92-107, 2013. ,
, Autism. Cell Rep, vol.14, pp.991-999
NMR-Based Metabolomics Reveal a Recovery from Metabolic Changes in the Striatum of 6-OHDA-Induced Rats Treated with Basic Fibroblast Growth Factor, Mol Neurobiol, vol.53, pp.6690-6697, 2016. ,